FUKOKU MUTUAL LIFE INSURANCE Co raised its position in CME Group Inc. (NASDAQ:CME – Free Report) by 30.8% in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 4,242 shares of the financial services provider’s stock after buying an additional 1,000 shares during the period. FUKOKU MUTUAL LIFE INSURANCE Co’s holdings in CME Group were worth $936,000 as of its most recent filing with the SEC.
A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the stock. Harbor Capital Advisors Inc. boosted its position in shares of CME Group by 0.6% during the third quarter. Harbor Capital Advisors Inc. now owns 7,810 shares of the financial services provider’s stock valued at $1,723,000 after buying an additional 45 shares during the last quarter. CVA Family Office LLC boosted its stake in shares of CME Group by 11.8% during the 3rd quarter. CVA Family Office LLC now owns 436 shares of the financial services provider’s stock worth $96,000 after purchasing an additional 46 shares during the period. Lester Murray Antman dba SimplyRich boosted its stake in shares of CME Group by 0.7% during the second quarter. Lester Murray Antman dba SimplyRich now owns 7,667 shares of the financial services provider’s stock valued at $1,507,000 after purchasing an additional 50 shares during the period. Zions Bancorporation N.A. lifted its holdings in shares of CME Group by 3.7% in the 3rd quarter. Zions Bancorporation N.A. now owns 1,530 shares of the financial services provider’s stock worth $338,000 after buying an additional 54 shares during the period. Finally, Quent Capital LLC boosted its position in CME Group by 10.2% during the 3rd quarter. Quent Capital LLC now owns 593 shares of the financial services provider’s stock valued at $131,000 after acquiring an additional 55 shares in the last quarter. 87.75% of the stock is currently owned by hedge funds and other institutional investors.
Insider Transactions at CME Group
In related news, Director Timothy S. Bitsberger sold 1,000 shares of the firm’s stock in a transaction that occurred on Wednesday, October 30th. The shares were sold at an average price of $226.96, for a total value of $226,960.00. Following the completion of the sale, the director now owns 10,589 shares of the company’s stock, valued at $2,403,279.44. This trade represents a 8.63 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, insider Timothy Francis Mccourt sold 1,374 shares of the stock in a transaction on Monday, October 28th. The shares were sold at an average price of $227.12, for a total value of $312,062.88. Following the completion of the transaction, the insider now directly owns 7,275 shares in the company, valued at approximately $1,652,298. This trade represents a 15.89 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 15,621 shares of company stock valued at $3,441,063 over the last three months. 0.30% of the stock is owned by corporate insiders.
CME Group Price Performance
CME Group (NASDAQ:CME – Get Free Report) last issued its quarterly earnings results on Wednesday, October 23rd. The financial services provider reported $2.68 EPS for the quarter, topping analysts’ consensus estimates of $2.65 by $0.03. CME Group had a net margin of 57.34% and a return on equity of 13.39%. The business had revenue of $1.58 billion during the quarter, compared to the consensus estimate of $1.59 billion. During the same period in the previous year, the firm posted $2.25 earnings per share. The company’s quarterly revenue was up 18.4% compared to the same quarter last year. On average, equities research analysts anticipate that CME Group Inc. will post 10.23 earnings per share for the current year.
CME Group Announces Dividend
The business also recently announced a quarterly dividend, which will be paid on Friday, December 27th. Investors of record on Monday, December 9th will be issued a $1.15 dividend. This represents a $4.60 dividend on an annualized basis and a dividend yield of 2.06%. The ex-dividend date of this dividend is Monday, December 9th. CME Group’s payout ratio is 48.37%.
Analysts Set New Price Targets
Several research analysts have recently weighed in on the stock. Deutsche Bank Aktiengesellschaft lowered their price target on shares of CME Group from $227.00 to $226.00 and set a “hold” rating on the stock in a research report on Monday. Piper Sandler raised their price objective on shares of CME Group from $240.00 to $250.00 and gave the stock an “overweight” rating in a research note on Monday, October 28th. Redburn Atlantic downgraded CME Group from a “buy” rating to a “neutral” rating and set a $244.00 target price on the stock. in a report on Tuesday, October 8th. Citigroup boosted their price target on shares of CME Group from $250.00 to $255.00 and gave the company a “buy” rating in a report on Thursday, October 24th. Finally, Keefe, Bruyette & Woods lifted their price target on CME Group from $212.00 to $213.00 and gave the company a “market perform” rating in a report on Thursday, July 25th. Four research analysts have rated the stock with a sell rating, seven have assigned a hold rating and four have given a buy rating to the company’s stock. According to data from MarketBeat.com, CME Group currently has a consensus rating of “Hold” and a consensus target price of $224.47.
View Our Latest Stock Analysis on CME
About CME Group
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.
See Also
- Five stocks we like better than CME Group
- Best Stocks Under $10.00
- Freshworks Stock Soars 50% – Is This the Perfect Entry Point?
- What Are Some of the Best Large-Cap Stocks to Buy?
- Why Meta Should Rally All The Way Into 2025
- How to Most Effectively Use the MarketBeat Earnings Screener
- 3 High-Yields Unfazed by the Election: Altria, Truist, Verizon
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.